| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |